B HALL STRATEGIES, LLC

Lobbying for TIBER CREEK GROUP ON BEHALF OF ASTELLAS PHARMA US, INC. · Pharmaceutical research and manufacturing company.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · $30,000.00 income · posted Jul 19, 2026

Lobbying activity 1

Pharmacy

Monitor issues related to drug pricing.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.